Lataa...
Targeting the Protein Ubiquitination Machinery in Melanoma by the NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924)
BACKGROUND: The neddylation pathway conjugates NEDD8 to cullin-RING ligases and controls the proteasomal degradation of specific proteins involved in essential cell processes. Pevonedistat (MLN4924) is a selective small molecule targeting the NEDD8-activating enzyme (NAE) and inhibits an early step...
Tallennettuna:
Julkaisussa: | Invest New Drugs |
---|---|
Päätekijät: | , , , , , , , , , , , , , |
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
2016
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5296256/ https://ncbi.nlm.nih.gov/pubmed/27783255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-016-0398-8 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|